Editorial to the Postmarketing Surveillance on the Clinical Use of Edoxaban in Patients With Nonvalvular Atrial Fibrillation (ETNA-AF Japan): One-Year Safety and Effectiveness Analyses

Journal of Arrhythmia - Netherlands
doi 10.1002/joa3.12340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley